Cargando…

Endocrine Side Effects in Patients Treated with Immune Checkpoint Inhibitors: A Narrative Review

Checkpoint inhibitors are monoclonal antibodies that elicit an anti-tumor response by stimulating immune system. Their use has improved the treatment of different types of cancer such as melanoma, breast carcinoma, lung, stomach, colon, liver, renal cell carcinoma, and Hodgkin’s lymphoma, but severa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Profili, Nicia I., Castelli, Roberto, Gidaro, Antonio, Merella, Alessandro, Manetti, Roberto, Palmieri, Giuseppe, Maioli, Margherita, Delitala, Alessandro P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419837/ https://www.ncbi.nlm.nih.gov/pubmed/37568563 http://dx.doi.org/10.3390/jcm12155161

Ejemplares similares

Aging of the Arterial System
por: Castelli, Roberto, et al.
Publicado: (2023)

A Diagnostic of Acquired Hemophilia Following PD1/PDL1 Inhibitors in Advanced Melanoma: The Experience of Two Patients and a Literature Review
por: Gidaro, Antonio, et al.
Publicado: (2022)

Prothrombotic and Inflammatory Markers in Elderly Patients with Non-Alcoholic Hepatic Liver Disease before and after Weight Loss: A Pilot Study
por: Gidaro, Antonio, et al.
Publicado: (2021)

Effect of rhTSH on Lipids
por: Delitala, Alessandro P., et al.
Publicado: (2020)

Incidence of Venous Thromboembolism in Multiple Myeloma Patients across Different Regimens: Role of Procoagulant Microparticles and Cytokine Release
por: Gidaro, Antonio, et al.
Publicado: (2022)

Ferric Carboxymaltose and Erythropoiesis-Stimulating Agent Treatment Reduces the Rate of Blood Transfusion in Refractory Anemia
por: Gidaro, Antonio, et al.
Publicado: (2022)

Endocrine side effects of immune checkpoint inhibitors
por: Cardona, Zulma, et al.
Publicado: (2023)

The side effects of immune checkpoint inhibitor therapy on the endocrine system
por: Goyal, Itivrita, et al.
Publicado: (2021)

Management of Obesity and Obesity-Related Disorders: From Stem Cells and Epigenetics to Its Treatment
por: Cruciani, Sara, et al.
Publicado: (2023)

How we treat endocrine complications of immune checkpoint inhibitors
por: Paschou, S.A., et al.
Publicado: (2021)

Abnormal Hemostatic Parameters and Risk of Thromboembolism Among Patients With COVID-19 Infection
por: Castelli, Roberto, et al.
Publicado: (2020)

Endocrine Toxicity and Outcomes in Patients With Metastatic Malignancies Treated With Immune Checkpoint Inhibitors
por: Al Ashi, Suleiman I, et al.
Publicado: (2021)

Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin?
por: Chiloiro, Sabrina, et al.
Publicado: (2023)

THU513 Are Endocrinologists Using CTCAE Grading System For Endocrine Side Effects Of Cancer Treatment With Immune Checkpoint Inhibitors?
por: Arnouk, Nelly, et al.
Publicado: (2023)

Anti-senescence efficacy of radio-electric asymmetric conveyer technology
por: Maioli, Margherita, et al.
Publicado: (2013)

THU093 Pituitary Enlargement And Hypopituitarism In Patients Treated With Immune Checkpoint Inhibitors: Two Sides Of The Same Coin?
por: Menotti, Sara, et al.
Publicado: (2023)

MON-603 Racial Distribution of Endocrine Complications in Oncology Patients Treated with Immune Checkpoint Inhibitors
por: Brooks, Danielle, et al.
Publicado: (2019)

Bendamustine and Rituximab, as First Line Treatment, in Intermediate, High Risk Splenic Marginal Zone Lymphomas of Elderly Patients
por: Castelli, Roberto, et al.
Publicado: (2016)

Checkpoint Inhibitor-Induced Colitis: From Pathogenesis to Management
por: Terrin, Maria, et al.
Publicado: (2023)

Immune checkpoint inhibitors, endocrine adverse events, and outcomes of melanoma
por: Karhapää, Hanna, et al.
Publicado: (2022)

SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Acute management of the endocrine complications of checkpoint inhibitor therapy
por: Higham, C E, et al.
Publicado: (2018)

Immune Checkpoint Inhibitors and Endocrine Disorders: A Position Statement from the Korean Endocrine Society
por: Kwon, Hyemi, et al.
Publicado: (2022)

Osteogenesis from Dental Pulp Derived Stem Cells: A Novel Conditioned Medium Including Melatonin within a Mixture of Hyaluronic, Butyric, and Retinoic Acids
por: Maioli, Margherita, et al.
Publicado: (2016)

Endocrine immune-related adverse events in patients with metastatic renal and urothelial cancer treated with immune checkpoint-inhibitors
por: Oppolzer, Immanuel Augustin, et al.
Publicado: (2023)

FRI539 Vitamin D and Endocrine Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors
por: He, Zijun, et al.
Publicado: (2023)

Immune checkpoint inhibitors in elderly patients treated for a lung cancer: a narrative review
por: Naltet, Charles, et al.
Publicado: (2021)

Melatonin and Vitamin D Interfere with the Adipogenic Fate of Adipose-Derived Stem Cells
por: Basoli, Valentina, et al.
Publicado: (2017)

Clinical diagnosis and treatment of immune checkpoint inhibitors‐related endocrine dysfunction
por: Duan, Lian, et al.
Publicado: (2020)

Moving Immune Checkpoint Inhibitors to Early Non-Small Cell Lung Cancer: A Narrative Review
por: Viscardi, Giuseppe, et al.
Publicado: (2022)

A case of thyroid metastasis from pancreatic cancer: case report and literature review
por: Delitala, Alessandro P, et al.
Publicado: (2014)

Amniotic fluid stem cells morph into a cardiovascular lineage: analysis of a chemically induced cardiac and vascular commitment
por: Maioli, Margherita, et al.
Publicado: (2013)

Melatonin and Vitamin D Orchestrate Adipose Derived Stem Cell Fate by Modulating Epigenetic Regulatory Genes
por: Santaniello, Sara, et al.
Publicado: (2018)

Left Atrial Appendage Occlusion in High Bleeding Risk Patients
por: Merella, Pierluigi, et al.
Publicado: (2019)

Myasthenia Gravis as an Immune-Mediated Side Effect of Checkpoint Inhibitors
por: Heleno, Caio T, et al.
Publicado: (2021)

Increased seroreactivity to proinsulin and homologous mycobacterial peptides in latent autoimmune diabetes in adults
por: Niegowska, Magdalena, et al.
Publicado: (2017)

Phenotypic heterogeneity of latent autoimmune diabetes in adults identified by body composition analysis
por: Pes, Giovanni Mario, et al.
Publicado: (2014)

The Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for Management
por: Girotra, Monica, et al.
Publicado: (2018)

Endocrine toxicity of immune checkpoint inhibitors: essential crosstalk between endocrinologists and oncologists
por: Illouz, Frédéric, et al.
Publicado: (2017)

Endocrine‐related adverse events associated with immune‐checkpoint inhibitors in patients with melanoma
por: Kassi, Eva, et al.
Publicado: (2019)

French Endocrine Society Guidance on endocrine side effects of immunotherapy
por: Castinetti, F, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_36351o2blfgom65541cmterngv